Family of patient who died during a clinical trial receive a six figure settlementBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7793 (Published 15 November 2012) Cite this as: BMJ 2012;345:e7793
- Clare Dyer
The family of a patient who died during a clinical trial at the Royal Marsden Hospital in London to test a five drug combination for treating testicular cancer has won a six figure sum in an out-of-court settlement.
Gareth Kingdon, 39, was the first patient to die from side effects during the multicentre TE23 trial, which was funded by the Medical Research Council to compare treatment of poor prognosis testicular cancer by five drugs instead of the standard three drug regime.
The family of another patient in the trial, 27-year-old Gary Foster, who was treated at University College London Hospital …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial